Volume 81, Issue 9 p. 1677
Errata
Free Access

A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach

Jaafar N. Haidar

Jaafar N. Haidar

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Qing-An Yuan

Qing-An Yuan

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Lin Zeng

Lin Zeng

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Mark Snavely

Mark Snavely

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Xenia Luna

Xenia Luna

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Haifan Zhang

Haifan Zhang

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Wei Zhu

Wei Zhu

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Dale L. Ludwig

Dale L. Ludwig

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
Zhenping Zhu

Zhenping Zhu

Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York, 10016

Search for more papers by this author
First published: 23 August 2013
Correspondence to: Jaafar N. Haidar. E-mail: [email protected]

Originally Published in PROTEINS: Structure, Function, and Bioinformatics 2012; 80(3):896–912 (DOI: 10.1002/prot.23246)

Due to a print error in the originally published version of this article, the Figure 4 caption is incorrect as published. The correct caption is listed below.

The humanization library mapped (backbone colored in red) on the structure of the M225/EGFR complex (PDB identifier 1YY9). Domain III of EGFR is in transparent spacefill and the Fv of M225 is in ribbon. The grafted CDRs (Advanced Chothia numbering scheme) of M225 are colored with light blue. The labels of the FR positions are colored red if amino acid biases were observed at these sites after competitive and/or standard panning (Table I); otherwise, the label is colored cyan. The red asterisk corresponds to FR positions that exclusively pass Filter II in Table I.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.